Is the complexity of vaccine and drug procurement driving much of the public confusion and misinformation? Added to it, is the scale and delivery conditions required to effectively inoculate the population. While Malaysia seems to be on track in its management of the Covid-19 vaccines, we have had a late start in the procurement and approval process. The question is why. Melisa Idris and Sharaad Kuttan speak to Azrul Mohd Khalib, CEO, Galen Centre for Health and Social Policy.